Jump to content

Dipanjan Pan

Add links
From Wikipedia, the free encyclopedia
Dipanjan Pan
NationalityAmerican
Occupation(s)Academic
Entrepreneur
Academic background
Alma materIndian Institute of Technology
Academic advisorsKaren L. Wooley
Academic work
InstitutionsWashington University in St. Louis

University of Illinois at Urbana-Champaign
University of Maryland Baltimore School of Medicine
University of Maryland Baltimore County

Pennsylvania State University

Dipanjan Pan is an Indian American academic who is the Dorothy Foehr Huck & J. Lloyd Huck Chair Professor in Nanomedicine at Pennsylvania State University.[1]

Early life and education

[edit]

Dipanjan Pan was born in India.[2] He obtained his doctoral degree from the Indian Institute of Technology and subsequently joined Washington University in St. Louis.[3] There, he collaborated with Karen L. Wooley on investigating the utilization of self-assembled polymeric nanoparticles for targeted drug delivery applications.[3]

Career

[edit]

Pan started his career in 2005 as an intellectual property analyst in chemistry at General Electric's John F. Welch Technology Centre.[4]

In 2007, he joined the Washington University School of Medicine in Saint Louis as a research instructor.[4][5] In 2010, he became an assistant professor in medicine and served until 2013, contributing to the field of cardiovascular research.[4][6]

In 2013, Pan joined the University of Illinois Urbana-Champaign as an assistant professor.[4]

In 2014, Pan co-founded InnSight Technology, a preclinical company, along with Leanne Labriola.[7] Two years later, in 2016, he co-founded KaloCyte, a company that has developed an artificial blood called Erythromer, with Allan Doctor and Philip Spinella.[8][9] He has served as a professor of radiology in the school of medicine, and professor of chemical and biochemical and environmental engineering at the University of Maryland, Baltimore County.[10][11]

Pan is the current head of the Pan Laboratory for Materials in Medicine.[12]

Research

[edit]

His research focuses on the development and application of nanoscale materials and techniques for the diagnosis and treatment of various diseases, particularly cancer and cardiovascular disorders.[3]

In 2014, Pan and his team reported a novel method for inhibiting cancer cell growth using nanotechnology, as detailed in a paper presented at the American Chemical Society conference.[13] The preliminary research demonstrated success in impeding breast cancer and melanoma cell growth in laboratory settings by delivering a synthetic compound mimicking venom from bees, snakes, and scorpions.[13][14]

In 2015, Pan, Leanne Labriola, and other team members developed a portable sensor named OcuCheck that assesses ocular injuries through the quantification of vitamin C concentration in a patient's tears at the University of Illinois.[15]

In 2018, Pan and other researchers at the University of Illinois created a gel utilizing gold nanoparticles which has the capability to rapidly detect ocular trauma.[16]

In 2020, Pan and his team initiated the development of rapid tests for detecting COVID-19.[17][18] Within six months, they created their first test, followed by four more by the end of 2021.[19] Three tests, including the Antisense test, have been licensed for commercialization and registered with the Food and Drug Administration.[19] Later, he founded a company called VitruVian Bio to further develop the test for commercial applications.[20][21]

In 2023, Dipanjan Pan and his research team developed the first rapid test for monkeypox, as reported in the journal Advanced Functional Materials.[22] It uses a selective molecular sensor that can detect the virus within minutes.[22] The method employs nanomaterial heterostructures, consisting of zero-dimensional spherical gold nanoparticles and two-dimensional hafnium disulfide nanoplatelets, as building blocks to create a platform technology capable of detecting trace amounts of genetic material in biological samples.[22]

Awards and recognition

[edit]
  • 2014: Elected Fellow of the Royal Society of Chemistry[4]
  • 2016: Nanomaterials Letter Researcher Award[4]
  • 2016: Elected Fellow of AHA[23]
  • 2018: Elected Fellow of ACC[24]
  • 2018: Dean's Award[25]
  • 2020: COVID-19 Hero Award[26]
  • 2021: Maryland Industrial Partnerships (MIPS) Award[27]
  • 2023: Elected Fellow of AIMBE[28]

Bibliography

[edit]
  • Nanomedicine: A Soft Matter Perspective
  • Personalized Medicine with a Nanochemistry Twist: Nanomedicine

References

[edit]
  1. ^ "Dipanjan Pan". 11 July 2022.
  2. ^ "Indian-Origins Among Researchers to Develop Portable Sensor to Quickly Detect Severe Eye Injury".
  3. ^ a b c "Professor Dipanjan Pan, PHD, FRSC, FAHA, FACC | - the Pan Research Group".
  4. ^ a b c d e f "Professor Dipanjan Pan".
  5. ^ "Pastries-like nanoparticles may help fight".
  6. ^ "Nanoparticles Can Detect Blood Clots".
  7. ^ "Tale of a teardrop: Pine eye specialist developing device that could signal disease".
  8. ^ "UMSOM bringing artificial blood product one step closer to reality | Maryland Daily Record". 6 February 2023.
  9. ^ "University of Maryland School of Medicine physician-scientist to lead high-budget research project to develop artificial blood".
  10. ^ "St. Louis biotech company moves to Baltimore to develop fake blood for real emergencies". Baltimore Sun.
  11. ^ "Rapid COVID-19 tests now available in some Maryland doctors' offices but questions about accuracy persist". Baltimore Sun.
  12. ^ Staff, Daily Record (June 23, 2022). "DIPANJAN PAN | Maryland Daily Record".
  13. ^ a b "Bee, scorpion and snake venom may hold cancer cure". CNN. 12 August 2014.
  14. ^ "Live Well: How to avoid 'brain freeze' from cold drinks and bee venom could help fight cancer".
  15. ^ "Vitamin C-detecting sensor could assess eye injuries on the spot". 10 December 2015.
  16. ^ "Color-changing sensor detects signs of eye damage in tears".
  17. ^ "Paper-based electrochemical sensor can detect COVID-19 in less than five minutes".
  18. ^ "Researchers develop experimental rapid COVID-19 test using nanoparticle technique".
  19. ^ a b "DIPANJAN PAN | Maryland Daily Record". 23 June 2022.
  20. ^ "Researchers develop experimental rapid COVID-19 test using nanoparticle technique: Advanced nanotechnology provides 'naked eye' visual detection of virus in 10 minutes".
  21. ^ "UMBC's Dipanjan Pan Develops Rapid Diagnostic Test for Virus Causing COVID-19 - UMBC: University of Maryland, Baltimore County". 9 June 2020.
  22. ^ a b c "First rapid test for mpox developed, tech adaptable for other emerging diseases | Penn State University". www.psu.edu.
  23. ^ "Fellow of the American Heart Association". University of Illinois Urbana-Champaign.
  24. ^ Communications, Grainger Engineering Office of Marketing and. "Pan elected Fellow of American College of Cardiology". bioengineering.illinois.edu.
  25. ^ Communications, Grainger Engineering Office of Marketing and. "Dipanjan Pan earns outstanding college of engineering research honor". bioengineering.illinois.edu.
  26. ^ Staff, Daily Record (June 23, 2022). "DIPANJAN PAN | Maryland Daily Record".
  27. ^ "UMBC Faculty, Alumni Entrepreneurs Receive Record Number Of MIPS Awards For Tech Collaborations - UMBC: University Of Maryland, Baltimore County". February 11, 2021.
  28. ^ "AIMBE" (PDF).
Retrieved from "https://en.wikipedia.org/w/index.php?title=Dipanjan_Pan&oldid=1224041055"